SEC Form 4 · accession 0001547522-16-000302
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Cunningham
Director
Period of report
Sep 19, 2016
Accepted (ET)
Sep 21, 2016 · 3:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.10 per share | Sep 19, 2016 | D | 7,334 | $7.83 | D | 2,070 | D | |
| Common Stock, par value $0.10 per share | Sep 19, 2016 | M | 10,000 | $5.75 | A | 12,070 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified stock options (right to buy) | $5.75 | Sep 19, 2016 | M | 10,000 | D | Oct 12, 2014 | Oct 12, 2016 | Common Stock | 10,000 | 0 | D |